Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha
This study is ongoing, but not recruiting participants.
Study NCT00031018 Information provided by National Center for Research Resources (NCRR)
First Received: February 20, 2002 Last Updated: February 4, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Memory Disorders
Alzheimer's Disease
Additional conditions recognized in this trial
Alzheimer Disease
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurodegenerative Diseases
Neurologic Manifestations
Signs and Symptoms
Tauopathies
Interventions listed in this trial
Aricept
IFN-alpha2A
Additional drug interventions recognized in this trial
Interferon Alfa-2a
Interferon-alpha
Interferons
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Center for Research Resources (NCRR)
Pfizer
Back to top of Main Content
